z-logo
open-access-imgOpen Access
Lysine Acetyltransferase PCAF Is a Key Regulator of Arteriogenesis
Author(s) -
A.J.N.M. Bastiaansen,
M.M. Ewing,
Hetty C. de Boer,
Tineke C. van der Pouw Kraan,
Margreet R. de Vries,
Erna A Peters,
S. Welten,
Ramon Arens,
Scott M. Moore,
James E. Faber,
J. Wouter Jukema,
Jaap F. Hamming,
A. Yaël Nossent,
Paul H.A. Quax
Publication year - 2013
Publication title -
arteriosclerosis thrombosis and vascular biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.007
H-Index - 270
eISSN - 1524-4636
pISSN - 1079-5642
DOI - 10.1161/atvbaha.113.301579
Subject(s) - arteriogenesis , pcaf , regulator , lysine , key (lock) , acetyltransferase , computer science , biology , cancer research , biochemistry , acetylation , gene , computer security , angiogenesis , amino acid
Therapeutic arteriogenesis, that is, expansive remodeling of preexisting collaterals, using single-action factor therapies has not been as successful as anticipated. Modulation of factors that act as a master switch for relevant gene programs may prove more effective. Transcriptional coactivator p300-CBP-associated factor (PCAF) has histone acetylating activity and promotes transcription of multiple inflammatory genes. Because arteriogenesis is an inflammation-driven process, we hypothesized that PCAF acts as multifactorial regulator of arteriogenesis.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom